Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Ruxolitinib treatment may cause eyelash growth.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

A patient with complete hair loss regrew all her hair using tofacitinib.

Baricitinib successfully treated severe hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.